Hem › Njurcancer (renalcelskarcinom) › Maryland › Baltimore
Kliniska studier för Njurcancer (renalcelskarcinom) i Baltimore, MD
10 studier för Njurcancer (renalcelskarcinom) söker deltagare vid platser i och runt Baltimore (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RekryterarFas 1
- Research Site, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekryterarObservationsstudieFriska volontärer välkomna
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- och 2 fler
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekryterarFas 1
- Exelixis Clinical Site #14, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
RekryterarFas 1/2
- Johns Hopkins Hospital, Baltimore
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RekryterarFas 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 mi bort
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
RekryterarFas 3
- Greater Baltimore Medical Center ( Site 0145), Baltimore
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
RekryterarFas 1
- Johns Hopkins University, Baltimore
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
RekryterarFas 1/2
- Johns Hopkins University (Data Collection Only), Baltimore
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekryterarFas 1
- Johns Hopkins Hospital /ID# 254056, Baltimore
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
RekryterarFas 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Njurcancer (renalcelskarcinom)-studier i andra städer
- Houston, TX35 studier
- New York City, NY27 studier
- Nashville, TN23 studier
- Dallas, TX23 studier
- St. Louis, MO23 studier
- Los Angeles, CA20 studier
- Boston, MA16 studier
- Baldwin Park, CA16 studier
- Pittsburgh, PA15 studier
- Philadelphia, PA15 studier
- Queens, NY15 studier
- Cleveland, OH14 studier
Andra studier i Baltimore
- Icke-småcellig lungcancer60 studier
- Bröstcancer47 studier
- Prostatacancer43 studier
- Lungcancer40 studier
- Cancer (alla typer)37 studier
- Bukspottkörtelcancer31 studier
- Kolorektal cancer31 studier
- Metastaserande cancer28 studier
- Övervikt26 studier
- Blåscancer24 studier
- Hjärtsvikt24 studier
- Äggstockscancer22 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.